Revenue (Quarterly) Chart

View Revenue (Quarterly) for NXGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 3.686M
March 31, 2026 2.65M
December 31, 2025 2.796M
September 30, 2025 2.934M
June 30, 2025 2.884M
March 31, 2025 2.806M
December 31, 2024 3.041M
September 30, 2024 2.94M
June 30, 2024 1.44M
March 31, 2024 1.266M
December 31, 2023 1.082M
September 30, 2023 1.221M
June 30, 2023 1.167M
March 31, 2023 0.62M
December 31, 2022 0.524M
September 30, 2022 0.568M
Date Value
June 30, 2022 0.561M
March 31, 2022 0.396M
December 31, 2021 0.533M
September 30, 2021 0.335M
June 30, 2021 0.417M
March 31, 2021 0.267M
December 31, 2020 0.101M
September 30, 2020 0.242M
June 30, 2020 0.091M
March 31, 2020 0.24M
December 31, 2019 0.176M
September 30, 2019 0.287M
June 30, 2019 0.125M
March 31, 2019 0.129M
December 31, 2018 0.461M
September 30, 2018 0.348M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 12.59B
Align Technology, Inc. 1.056B
AngioDynamics, Inc. 86.61M
Accuray, Inc. 100.92M
Alphatec Holdings, Inc. 213.51M